Omeros Corp. buy tamam
Start price
02.02.19
/
50%
€12.43
Target price
04.11.21
€20.67
Performance (%)
-50.11%
End price
05.11.21
€6.20
Summary
This prediction ended on 05.11.21 with a price of €6.20. Massive losses of -50.11% were the result for the BUY prediction by tamam. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Omeros Corp. | -2.614% | -2.614% | 22.203% | 297.333% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% | 64.626% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% | 109.421% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% | 57.591% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% | 68.003% |
Comments by tamam for this prediction
In the thread Omeros Corp. diskutieren
tamam stimmt der Buy-Einschätzung von marge zu
tamam stimmt am 02.02.2019 der Buy-Einschätzung von marge mit dem Kursziel 34$ zu.
Überschrift: Orphan drug market support blockbuster potential for OMS721
Kursziel geändert auf 20,668
In the thread Trading Omeros Corp.
Die von tamam gewählte maximale Laufzeit wurde überschritten


